Past News Releases

International Commercial Television, Inc. (ICTL), (or “ICTV”), a direct response marketing and branding company focused on the health, wellness and beauty sector, has launched Elastin-rp, a branded system of cosmetic formulations designed to help improve the elasticity of the skin, thereby diminishing the appearance of fine lines and wrinkles. Elastin-rp addresses the anti-aging market and is delivered using a unique body heat-activated system which enables the BioLastin Complex to penetrate quickly to help stimulate your skin’s natural ability to replenish elastin and collagen.

ICTV acquired the exclusive worldwide rights to Elastin-rp via a licensing agreement with BioActive Skin Technologies in July 2013. ICTV spent several months re-editing an infomercial it acquired the rights to in the licensing agreement before its media test on January 18. In clinical studies, Elastin-rp has proven to increase skin elasticity by 50%, helping to repair, rejuvenate, restore and naturally fill-in for flawless skin. The independent clinical trial confirmed significant improvement in skin hydration in 15 minutes, significant reduction in crows feet and general fine lines and wrinkles and significant improvement in skin firmness, lifting and radiance. The Elastin-rp infomercial is hosted by Brenda Strong, who is an elastin-rp user, spokesperson and TV personality. For more information, please go to http://www.TryElastin.com.

Richard Ransom, ICTV’s President and CFO stated, “We are very excited about the prospects for Elastin-rp, having demonstrated very strong clinical trials and testimonials. We believe it will be very well-positioned and perceived to our audience seeking health and beauty products, especially in the anti-aging area. Elastin-rp is sold on a continuity auto-ship business model and will provide a very predictable revenue stream as we ramp it up. There is also high demand for Elastin-rp in the international market and we are pleased to announce that the first order of Elastin-rp has placed through our Australian/New Zealand distributor.”

International Commercial Television, Inc. sells various health, wellness and beauty products through infomercials and other channels primarily in the United States. ICTV utilizes a distinctive marketing strategy and multi-channel distribution model to develop, market and sell products through infomercials, live home shopping television, specialty outlets and online shopping. It offers health and beauty products, including DermaWand, a skin care device that reduces the appearance of fine lines and wrinkles, and helps improves skin tone and texture; and DermaVitál, a professional quality skin care range that effects superior hydration. International Commercial Television Inc. was founded in 1993 and headquartered in Wayne, Pennsylvania.

Forward-Looking Statements

Forward-Looking Statements. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2012, including but not limited to the discussion under "Risk Factors" therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.